Michael Shawn Moran Eagle Pharmaceuticals, Inc. (EGRX) insider trading activity

EGRX Quotes by TradingView

Michael Shawn Moran is EVP, Chief Commercial Officer of EAGLE PHARMACEUTICALS, INC.. Currently has a direct ownership of 32,115 shares of EGRX, which is worth approximately $30,509. The most recent transaction as insider was on Feb 28, 2022, when has been sold 10,400 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32.1K
0% 3M change
0% 12M change
Total Value Held $30,509

Michael Shawn Moran Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 28 2022
BUY
Grant, award, or other acquisition
-
10,400 Added 24.46%
32,115 Common Stock
Feb 02 2022
SELL
Payment of exercise price or tax liability
$33,412 $45.03 p/Share
742 Reduced 3.3%
21,715 Common Stock
Jan 31 2022
SELL
Payment of exercise price or tax liability
$9,647 $45.94 p/Share
210 Reduced 0.93%
22,457 Common Stock
Jan 07 2022
SELL
Payment of exercise price or tax liability
$4,557 $50.63 p/Share
90 Reduced 0.4%
22,667 Common Stock
Jan 05 2022
SELL
Payment of exercise price or tax liability
$76,593 $50.69 p/Share
1,511 Reduced 6.23%
22,757 Common Stock
MSM

Michael Shawn Moran

EVP, Chief Commercial Officer
Woodcliff Lake, NJ

Track Institutional and Insider Activities on EGRX

Follow EAGLE PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EGRX shares.

Notify only if

Insider Trading

Get notified when an Eagle Pharmaceuticals, Inc. insider buys or sells EGRX shares.

Notify only if

News

Receive news related to EAGLE PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EGRX